Revolutionary #Tick Repelling Drug Shows Promise in Human Trials #lymedisease

Imagine a world where you could take a pill to protect yourself from Lyme disease and other tick-borne illnesses. Lyme disease is the most common vector-borne disease in the U.S., with over 30 million Americans at risk. Tarsus Pharmaceuticals has developed an orally administered drug that shows promising results in killing ticks. The drug demonstrated a mean tick mortality rate of up to 97% and remained effective for 30 days. The drug contains lotilaner, which enters the bloodstream and kills ticks once they start feeding. Preventing Lyme disease could save billions in healthcare costs and improve the lives of those at risk. The company envisions a future where people can protect themselves from ticks before they even bite. This groundbreaking tick prevention drug could revolutionize how we protect ourselves from Lyme disease and other tick-borne illnesses.